1. Home
  2. CRESY vs AVBP Comparison

CRESY vs AVBP Comparison

Compare CRESY & AVBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRESY
  • AVBP
  • Stock Information
  • Founded
  • CRESY 1936
  • AVBP 2021
  • Country
  • CRESY Argentina
  • AVBP United States
  • Employees
  • CRESY N/A
  • AVBP N/A
  • Industry
  • CRESY Real Estate
  • AVBP
  • Sector
  • CRESY Finance
  • AVBP
  • Exchange
  • CRESY Nasdaq
  • AVBP NYSE
  • Market Cap
  • CRESY 815.5M
  • AVBP 925.7M
  • IPO Year
  • CRESY 1997
  • AVBP 2024
  • Fundamental
  • Price
  • CRESY $12.09
  • AVBP $24.41
  • Analyst Decision
  • CRESY
  • AVBP Strong Buy
  • Analyst Count
  • CRESY 0
  • AVBP 5
  • Target Price
  • CRESY N/A
  • AVBP $36.80
  • AVG Volume (30 Days)
  • CRESY 235.0K
  • AVBP 157.5K
  • Earning Date
  • CRESY 02-07-2025
  • AVBP 02-02-2025
  • Dividend Yield
  • CRESY 8.21%
  • AVBP N/A
  • EPS Growth
  • CRESY N/A
  • AVBP N/A
  • EPS
  • CRESY N/A
  • AVBP N/A
  • Revenue
  • CRESY $751,941,316.00
  • AVBP N/A
  • Revenue This Year
  • CRESY N/A
  • AVBP N/A
  • Revenue Next Year
  • CRESY N/A
  • AVBP N/A
  • P/E Ratio
  • CRESY N/A
  • AVBP N/A
  • Revenue Growth
  • CRESY N/A
  • AVBP N/A
  • 52 Week Low
  • CRESY $6.56
  • AVBP $14.35
  • 52 Week High
  • CRESY $14.23
  • AVBP $36.37
  • Technical
  • Relative Strength Index (RSI)
  • CRESY 41.82
  • AVBP 36.68
  • Support Level
  • CRESY $12.64
  • AVBP $23.63
  • Resistance Level
  • CRESY $14.03
  • AVBP $26.54
  • Average True Range (ATR)
  • CRESY 0.74
  • AVBP 1.47
  • MACD
  • CRESY -0.16
  • AVBP -0.17
  • Stochastic Oscillator
  • CRESY 9.09
  • AVBP 16.00

About CRESY Cresud S.A.C.I.F. y A.

Cresud SACIF y A is engaged in agricultural business and urban properties and investment business. Under its agricultural business the company produces oilseed grains and cereals, sugar cane and meat. The Agricultural business of the company is further comprised of four reportable segments which are Agricultural production, Land transformation and Sales, Corporate and Other segments. The company participates in the real estate business in Argentina through its subsidiary IRSA. The real estate business is further comprised of five reportable segments, namely Shopping Malls, Offices, Sales and Developments, Hotels and others.

About AVBP ARRIVENT BIOPHARMA INC

ArriVent BioPharma Inc is a clinical stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize team's deep drug development experience to maximize the potential of lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

Share on Social Networks: